Cue Biopharma CUE
NASDAQ CUE
$18.95 +1.91 (+11.21%)
At close: Oct 21, 2026 · 4:00 PM EDT

Cue Biopharma (CUE) Times Interest Earned (2022)

Updated

Cue Biopharma's Times Interest Earned came in at -88.96 for Q3 2022.

Analysis

Cue Biopharma (CUE) Times Interest Earned (2022) Analysis & Trends

Over the trailing twelve months to Sep 30, 2022, Cue Biopharma reported Times Interest Earned of -130.29.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 25.41
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 10.28
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 7.27
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 5.22
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -42.08
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Cue Biopharma 121.14 Mn 30.41 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -88.96
Jun 30, 2022 -63.54
Mar 31, 2022 -569.52
API Access

Cue Biopharma Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=CUE&period=max&api_key=YOUR_API_KEY